David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Grand Canyon Education
LOPE
$3.84B
| $37M | 0.05% |
331,150
+258,123
| +353% | +$28.3M |
|
452
Chemed
CHE
$7.07B
| $36.9M | 0.05% |
+114,721
| New | +$35.9M |
|
453
PUT
Bausch Health
BHC
$2.41B
| $36.8M | 0.05% |
1,583,200
-796,500
| -33% | -$16.5M |
|
454
Exelixis
EXEL
$13.4B
| $36.8M | 0.05% |
1,709,611
-44,699
| -3% | -$924K |
|
|
TWOU
455
DELISTED
2U Inc
TWOU
| $36.7M | 0.05% |
14,652
+6,920
| +89% | +$18.4M |
|
|
CTLT
456
DELISTED
CATALENT, INC.
CTLT
| $36.7M | 0.05% |
876,687
+800,509
| +1,051% | +$32.3M |
|
|
CJ
457
DELISTED
C&J Energy Services, Inc.
CJ
| $36.7M | 0.05% |
1,555,827
-302,149
| -16% | -$8.3M |
|
458
PUT
AbbVie
ABBV
$468B
| $36.1M | 0.05% |
389,800
+76,200
| +24% | +$7.44M |
|
459
Service Corp International
SCI
$11.4B
| $36.1M | 0.05% |
1,008,680
+282,456
| +39% | +$10.5M |
|
460
Baxter International
BAX
$13.6B
| $35.8M | 0.05% |
484,319
-591,086
| -55% | -$41.7M |
|
461
PUT
Kroger
KR
$35.5B
| $35.7M | 0.05% |
1,253,200
-40,700
| -3% | -$1.02M |
|
462
Haemonetics
HAE
$4.95B
| $35.6M | 0.05% |
397,321
+346,415
| +680% | +$29.3M |
|
|
VMRK
463
Vivmark Residential
VMRK
$25B
| $35.6M | 0.05% |
559,308
+40,892
| +8% | +$2.55M |
|
464
CALL
Oracle
ORCL
$422B
| $35.6M | 0.05% |
807,800
+694,000
| +610% | +$32M |
|
|
WLL
465
DELISTED
Whiting Petroleum Corporation
WLL
| $35.1M | 0.05% |
8,879
+7,829
| +746% | +$27.1M |
|
466
Monster Beverage
MNST
$93.6B
| $35M | 0.05% |
2,443,428
+2,207,384
| +935% | +$29.8M |
|
467
Telus
TU
$15.6B
| $34.9M | 0.05% |
1,964,384
+300,800
| +18% | +$5.32M |
|
468
Entergy
ETR
$48.8B
| $34.9M | 0.05% |
863,726
-133,738
| -13% | -$5.29M |
|
469
PUT
Biogen
BIIB
$32B
| $34.8M | 0.05% |
119,800
+54,500
| +83% | +$15.3M |
|
|
NVO
470
Novo Nordisk
NVO
$207B
| $34.7M | 0.05% |
+1,503,382
| New | +$35.7M |
|
471
Simon Property Group
SPG
$70.6B
| $34.6M | 0.05% |
203,141
+110,720
| +120% | +$17.6M |
|
472
PUT
Macy's
M
$6B
| $34.4M | 0.04% |
919,700
-18,700
| -2% | -$627K |
|
473
Visteon
VC
$2.83B
| $34.4M | 0.04% |
266,168
-52,303
| -16% | -$6.54M |
|
474
PUT
Western Digital
WDC
$166B
| $34.3M | 0.04% |
587,015
+353,638
| +152% | +$22.5M |
|
475
CVS Health
CVS
$119B
| $34.2M | 0.04% |
532,004
-405,452
| -43% | -$26.7M |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.